China Cord Blood Corp., of Hong Kong, said its board of directors has received a non-binding proposal letter from Golden Meditech Holdings Ltd. proposing to acquire all of the outstanding ordinary shares of the company not already directly or indirectly owned by Golden Meditech for $6.40 per share in cash.